Cite

HARVARD Citation

    McCall, M. et al. (n.d.). Comparison of extended to standard half-life recombinant factor VIII therapy in patients with hemophilia A on prophylactic therapy. Journal of drug assessment. pp. 46-47. [Online]. 
  
Back to record